Patent assignee · US · COMPANY

Protagonist Therapeutics, Inc.

🏢 View company profile →
32Patents
32Active
32Granted
53Portfolio score

Filing activity: Oct 10, 2013 → Sep 28, 2023

Most-cited patents

PatentTitleAreaCited byStatus
US9273093B2 α4β7 peptide dimer antagonists Human Necessities 29 Active
US9518091B2 A4B7 peptide monomer and dimer antagonists Human Necessities 28 Active
US9624268B2 Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases Physics 26 Active
US9822157B2 Hepcidin analogues and uses thereof Human Necessities 25 Active
US9809623B2 α4β7 peptide monomer and dimer antagonists Human Necessities 24 Active
US9714270B2 a4B7 integrin thioether peptide antagonists Human Necessities 24 Active
US10030061B2 Hepcidin analogues and uses thereof Human Necessities 21 Active
US10035824B2 Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases Physics 19 Active
US10059744B2 α4β7 thioether peptide dimer antagonists Human Necessities 19 Active
US10023614B2 Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases Physics 19 Active
US10196424B2 Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases Physics 17 Active
US10301371B2 Cyclic monomer and dimer peptides having integrin antagonist activity Human Necessities 16 Active
US10442846B2 Hepcidin analogues and uses thereof Human Necessities 15 Active
US10501515B2 Hepcidin analogues and uses thereof Human Necessities 15 Active
US10278957B2 Opioid agonist peptides and uses thereof Chemistry; Metallurgy 13 Active
US10787490B2 Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases Human Necessities 13 Active
US10626146B2 α4β7 thioether peptide dimer antagonists Human Necessities 12 Active
US10407468B2 Methods for synthesizing α4β7 peptide antagonists Human Necessities 11 Active
US11041000B2 Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases Chemistry; Metallurgy 8 Active
US11111272B2 α4α7 peptide monomer and dimer antagonists Human Necessities 8 Active
US10941183B2 Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases Physics 8 Active
US10729676B2 Opioid agonist peptides and uses thereof Chemistry; Metallurgy 8 Active
US11472842B2 Analogues of hepcidin mimetics with improved in vivo half lives Human Necessities 4 Active
US11753443B2 Conjugated hepcidin mimetics Human Necessities 2 Active
US11807674B2 Hepcidin analogues and uses thereof Human Necessities 2 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.